OTCMKTS:AXIMAxim Biotechnologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Axim Biotechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.25 -0.03 (-10.72 %) (As of 07/14/2020 09:09 AM ET) Add Compare Share Today's Range$0.21Now: $0.25▼$0.2850-Day Range$0.27MA: $0.37▼$0.5552-Week Range$0.10Now: $0.25▼$0.95Volume326,900 shsAverage Volume311,174 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Axim Biotechnologies, Inc., a biotechnology company, researches, develops, produces, and sells pharmaceutical, nutraceutical, and cosmetic products. It also engages in the extraction and purification of cannabinoids technologies based on its proprietary technologies. The company sells its products through Internet, direct-to-consumer health and wellness stores, collectives, cooperatives, and affiliate sales and master distributors. Axim Biotechnologies, Inc. was formerly known as Axim International Inc. and changed its name to Axim Biotechnologies, Inc. in July 2014. The company was founded in 2010 and is headquartered in New York, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Axim Biotechnologies. Previous Next 2.2 Community Rank Outperform VotesAxim Biotechnologies has received 21 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAxim Biotechnologies has received 26 “underperform” votes. (Add your “underperform” vote.)Community SentimentAxim Biotechnologies has received 55.32% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Axim Biotechnologies and other stocks. Vote “Outperform” if you believe AXIM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AXIM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAxim Biotechnologies does not currently pay a dividend.Dividend GrowthAxim Biotechnologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Axim Biotechnologies insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.44 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AXIM Previous Symbol CUSIPN/A CIK1514946 Webaximbiotech.com Phone212-751-0001Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees4 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:AXIM Rates by TradingView Receive AXIM News and Ratings via Email Sign-up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter. Axim Biotechnologies (OTCMKTS:AXIM) Frequently Asked Questions How has Axim Biotechnologies' stock been impacted by COVID-19 (Coronavirus)? Axim Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AXIM stock has increased by 40.3% and is now trading at $0.2499. View which stocks have been most impacted by Coronavirus. Has Axim Biotechnologies been receiving favorable news coverage? Media coverage about AXIM stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Axim Biotechnologies earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Axim Biotechnologies. Who are some of Axim Biotechnologies' key competitors? Some companies that are related to Axim Biotechnologies include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Aortech International (RUA), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. What other stocks do shareholders of Axim Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Axim Biotechnologies investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), Charlotte's Web (CWBHF), KushCo (KSHB), Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Tilray (TLRY), Aurora Cannabis (ACB) and CV Sciences (CVSI). Who are Axim Biotechnologies' key executives? Axim Biotechnologies' management team includes the following people: Dr. George E. Anastassov, Founder & Chairman (Age 56)Mr. John W. Huemoeller II, CEO & Director (Age 64)Mr. Robert T. Malasek, CFO & Sec. (Age 51)Mr. Lekhram Changoer, CTO & Director (Age 52)Dr. Philip A. Van Damme D.M.D., M.D., DMD, MD, Ph.D., Chief Medical Officer & Director (Age 66) What is Axim Biotechnologies' stock symbol? Axim Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM." How do I buy shares of Axim Biotechnologies? Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Axim Biotechnologies' stock price today? One share of AXIM stock can currently be purchased for approximately $0.25. What is Axim Biotechnologies' official website? The official website for Axim Biotechnologies is aximbiotech.com. How can I contact Axim Biotechnologies? The company can be reached via phone at 212-751-0001. This page was last updated on 7/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
